ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Boc-L-homophenylalanine
C15H21NO4
279.33 g/mol
Pharmaceutical IntermediateWarning

(2S)-2-{[(tert-butoxy)carbonyl]amino}-4-phenylbutanoic acid

CAS100564-78-1EC692-740-1
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a protected amino acid derivative used as a building block in peptide synthesis. Its structure incorporates a tert-butoxycarbonyl (Boc) protecting group and a homophenylalanine backbone, making it suitable for solid-phase or solution-phase peptide assembly.

Peptide building block for synthetic chemistryIntermediate in pharmaceutical manufacturing

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing (2S)-2-{[(tert-butoxy)carbonyl]amino}-4-phenylbutanoic acid?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ApplicationSame Use

S-Trityl-D-penicillamine

CAS150025-01-7

pharmaceutical intermediate

ApplicationSame Use

Fmoc-Ile-Aib-OH

CAS2171139-20-9

pharmaceutical intermediate

ReferenceSame Category

Tx-1041

CAS1006-23-1

pharmaceutical intermediate

ReferenceSame Category

2-bromo-4-fluorobenzoic acid

CAS1006-41-3

pharmaceutical intermediate

ReferenceSame Category

O-acetyl losartan

CAS1006062-27-6

pharmaceutical intermediate

ReferenceSame Category

(1S)-2-chloro-1-(3,4-difluorophenyl)ethanol

CAS1006376-60-8

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name

(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-phenylbutanoic acid

InChIKey

MCODLPJUFHPVQP-LBPRGKRZSA-N

SMILES

CC(C)(C)OC(=O)N[C@@H](CCC1=CC=CC=C1)C(=O)O

Synonyms (24)
  • BOC-D-HOMOPHENYL-ALA
  • BOC-HFE-OH
  • BOC-HOPHE-OH
  • Boc-Homophe-OH
  • Boc-Homophe-OH, >=98.0% (TLC)
  • Boc-L-Homophe
  • Boc-L-homophenylalanine
  • Boc-homophenylalanine
  • Carfilzomib Impurity 12
  • Carfilzomib Impurity 13
  • N-Boc-Homophenylalanine
  • N-boc-L-homophenylalanine

Sourcing (2S)-2-{[(tert-butoxy)carbonyl]amino}-4-phenylbutanoic acid?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→